Voxergolide
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Voxergolide (INN; developmental code name RU-41656), also known as 6-methyl-8-[(methylthio)methyl]-9-oxaergoline, is a dopamine receptor agonist of the 9-oxaergoline family described as an anti-anoxic and anti-ischemic agent which was never marketed.[1][2][3] It acts specifically as a dopamine D2 receptor agonist.[4][3]
Other namesRU41656; 6-Methyl-8-[(methylthio)methyl]-9-oxaergoline
| Clinical data | |
|---|---|
| Other names | RU41656; 6-Methyl-8-[(methylthio)methyl]-9-oxaergoline |
| Drug class | Dopamine D2 receptor agonist |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H20N2OS |
| Molar mass | 288.41 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
See also
- Substituted 9-oxaergoline
- RU-29717 (N-propyl-9-oxaergoline)
- 6-Ethyl-9-oxaergoline (EOE)
- Naxagolide